Search results for: htlv
HTLV
WELCOME TO THE HTLV HTLV CASE STUDY GVN HTLV Case Study 1 Global Virus Network Issues Open Letter to WHO On Potent Human Carcinogen – HTLV-1 GVN calls for better screening for Human T-Cell Leukemia Viruses in transplant organs
Read MoreHTLV-1 Letter
ABOUT HTLV-1 LETTER Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing…
Read MoreHTLV-1 TASK FORCE
ABOUT THE HTLV-1 TASK FORCE HTLV WORLD DAY – NOVEMBER 10TH – CLICK HERE TO LEARN MORE ABOUT THE TASK FORCE The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo, GVN co-founder…
Read MoreGlobal Virus Network (GVN) Catalyzes World Health Organization (WHO) to Officially Recognize HTLV-1 as Threatening Pathogen to Humans
March 29, 2021 During GVN’s 9th International Meeting in Melbourne, Australia on September 25-27, 2017 in partnership with the Peter Doherty Institute and the Institut Pasteur, researchers held impressive sessions on one of the most potent human carcinogens, human T cell leukemia virus-1 (HTLV-1). The sessions were organized by Dr. Sharon Lewin, Director of The…
Read MoreTime to eradicate HTLV-1: an open letter to WHO
Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing to you today…
Read MoreDeadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1
Deadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1 Thirty-eight years ago, Dr. Robert Gallo and his colleagues discovered Human T-cell Leukemia Virus 1 (HTLV-1), the first known human retrovirus and the first virus shown to cause cancer. This breakthrough is perhaps best known because it led another momentous discovery, the identification of HIV.…
Read MoreHTLV-1 Task Force
HTLV-1 Task Force HTLV world day – November 10th – click here to learn more About The Task Force The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo,…
Read MoreAction Committees
WELCOME TO THE Action Committees Action Committees, formerly known as Task Forces and Watch Groups, are a central initiative of the GVN, uniting experts across academic, institutional, and corporate partners to address pressing viral challenges. Each committee focuses on a specific viral category or emerging threat, such as poxviruses, respiratory viruses, hemorrhagic fever viruses, arboviruses,…
Read MoreGlobal Virus Network Welcomes New Centers of Excellence Across the Americas
University of South Florida’s Institute for Translational Virology & Innovation, Brazil’s Department of Microbiology, Immunology and Parasitology at the Federal University of São Paulo, and Canada’s Pathogen Research Centre at Western University bring advanced expertise in HIV, arboviruses, and pandemic preparedness TAMPA, FL, USA, October 30, 2025 – The Global Virus Network (GVN), a coalition…
Read MoreGlobal Virus Network Meeting Unites Caribbean and Latin America to Tackle Emerging Viral Threats
Dr. Christine Carrington of UWI St. Augustine Honored with Inaugural GVN Regional Leadership Award for Advancing Genomic Surveillance and Pandemic Preparedness Participants of the GVN Regional Meeting: Caribbean and Latin America held in Kingston, Jamaica May 1-2, 2025. KINGSTON, JAMAICA – May 8, 2025 – The Global Virus Network (GVN), in partnership with The University…
Read More